Original language | English (US) |
---|---|
Pages (from-to) | 491-493.e4 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 125 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2010 |
Externally published | Yes |
Bibliographical note
Funding Information:Disclosure of potential conflict of interest: R. F. Lemankse, Jr, is on the speakers' bureau for Merck, AstraZeneca, Doembecher Children's Hospital, Washington University, Medicus Group, Park Nicolet Institute, ACAAI, LA Allergy Society, Michigan Allergy/Asthma Society, Medical College of Wisconsin, Fund for Medical Research and Education (Detroit), Children's Hospital of Minnesota, Toronto Allergy Society, AAAAI, Beaumont Hospital (Detroit), University of Illinois, Canadian Society of Allergy and Clinical Immunology, and New York Presbyterian; has consultant arrangements with AstraZeneca, Map Pharmaceuticals, Gray Consulting, Smith Research, Inc, Merck Childhood Asthma Network, Novartis, Quintiles/Innovax, RC Horowitz & Co, Inc, International Meetings and Science, and Scienomics; is an author of Up-to-Date; and is a textbook editor for Elsevier, Inc. Christine M. Seroogy receives grant support from the NIH , the AAAAI Research Trust, and Midwest Athletes Against Childhood Cancer. The rest of the authors have declared that they have no conflict of interest.
Funding Information:
Supported by NIAID/NIH R01 HL080072-01 , NHLBI/NIH P01 HL70831-01 , and NIAID/NIH T32 AI007635 (T32) .